These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes. Plass C; Byrd JC; Raval A; Tanner SM; de la Chapelle A Br J Haematol; 2007 Dec; 139(5):744-52. PubMed ID: 17961188 [TBL] [Abstract][Full Text] [Related]
4. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. Dobosy JR; Roberts JL; Fu VX; Jarrard DF J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351 [TBL] [Abstract][Full Text] [Related]
5. Epigenetics in human disease and prospects for epigenetic therapy. Egger G; Liang G; Aparicio A; Jones PA Nature; 2004 May; 429(6990):457-63. PubMed ID: 15164071 [TBL] [Abstract][Full Text] [Related]
6. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Clark SJ Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Vaissière T; Sawan C; Herceg Z Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic considerations for endometrial cancer prevention, diagnosis and treatment. Zhou XC; Dowdy SC; Podratz KC; Jiang SW Gynecol Oncol; 2007 Oct; 107(1):143-53. PubMed ID: 17692907 [TBL] [Abstract][Full Text] [Related]
9. DNA methylation as a regulatory mechanism for gene expression in mammals. Serman A; Vlahović M; Serman L; Bulić-Jakus F Coll Antropol; 2006 Sep; 30(3):665-71. PubMed ID: 17058541 [TBL] [Abstract][Full Text] [Related]
11. The new frontier in cancer research: deciphering cancer epigenetics. Lohrum M; Stunnenberg HG; Logie C Int J Biochem Cell Biol; 2007; 39(7-8):1450-61. PubMed ID: 17442611 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact. Mansouri L; Wierzbinska JA; Plass C; Rosenquist R Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes in cancer. Grønbaek K; Hother C; Jones PA APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143 [TBL] [Abstract][Full Text] [Related]
15. Epigenetics, disease, and therapeutic interventions. Lu Q; Qiu X; Hu N; Wen H; Su Y; Richardson BC Ageing Res Rev; 2006 Nov; 5(4):449-67. PubMed ID: 16965942 [TBL] [Abstract][Full Text] [Related]
16. The role of epigenetic alterations in pancreatic cancer. Sato N; Goggins M J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of epigenetics in urological cancers. Ramachandran K; Soloway MS; Singal R; Manoharan M Can J Urol; 2007 Jun; 14(3):3535-41. PubMed ID: 17594743 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma. Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624 [TBL] [Abstract][Full Text] [Related]